{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:30:36Z","timestamp":1783035036118,"version":"3.54.6"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,2,23]],"date-time":"2008-02-23T00:00:00Z","timestamp":1203724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s10549-008-9941-4","type":"journal-article","created":{"date-parts":[[2008,2,22]],"date-time":"2008-02-22T18:07:41Z","timestamp":1203703661000},"page":"321-326","source":"Crossref","is-referenced-by-count":13,"title":["Long-term \u201cprotective\u201d effect of aromatase inhibitors on the endometrium of postmenopausal breast cancer patients"],"prefix":"10.1007","volume":"113","author":[{"given":"O.","family":"Markovitch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Aviram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,23]]},"reference":[{"key":"9941_CR1","first-page":"660","volume":"81","author":"E Lahti","year":"1993","unstructured":"Lahti E, Blanco G, Kauppila A et al (1993) Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 81:660\u2013664","journal-title":"Obstet Gynecol"},{"key":"9941_CR2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/gyno.1994.1029","volume":"52","author":"I Cohen","year":"1994","unstructured":"Cohen I, Rosen DJD, Shapira J et al (1994) Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol 52:185\u2013190","journal-title":"Gynecol Oncol"},{"key":"9941_CR3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1006\/gyno.1996.0064","volume":"60","author":"S Cecchini","year":"1996","unstructured":"Cecchini S, Ciatto S, Bonardi R et al (1996) Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients with tamoxifen treatment. Gynecol Oncol 60:409\u2013411","journal-title":"Gynecol Oncol"},{"key":"9941_CR4","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1200\/JCO.2000.18.20.3464","volume":"18","author":"B Gerber","year":"2000","unstructured":"Gerber B, Krause A, Muller H et al (2000) Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. J Clin Oncol 18:3464\u20133470","journal-title":"J Clin Oncol"},{"key":"9941_CR5","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1002\/cncr.10587","volume":"94","author":"I Cohen","year":"2002","unstructured":"Cohen I, Azaria R, Shapira J, Dror Y, Tepper R (2002) Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women. Cancer 94:3101\u20133106","journal-title":"Cancer"},{"key":"9941_CR6","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","volume":"359","author":"The ATAC (Arimidex Tamoxifen Alone or in Combination) Trialists\u2019 Group","year":"2002","unstructured":"The ATAC (Arimidex Tamoxifen Alone or in Combination) Trialists\u2019 Group (2002) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial. Lancet 359:2131\u20132139","journal-title":"Lancet"},{"key":"9941_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMoa032312","volume":"349","author":"P Goss","year":"2003","unstructured":"Goss P, Ingle J, Martino S (2003) A randomized trial of letrozole in postmenopausal women after 5\u00a0years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349:1\u201310","journal-title":"N Engl J Med"},{"key":"9941_CR8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/humrep\/dei322","volume":"21","author":"S Duffy","year":"2006","unstructured":"Duffy S, Jackson TL, Lansdown M et al (2006) The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2\u00a0years of treatment. Human Reprod 21:545\u2013553","journal-title":"Human Reprod"},{"key":"9941_CR9","unstructured":"Garrone O, Mezi S, Occelli M et al (2003) Reversal of tamoxifen induced endometrial modifications by switching to letrozole in early breast cancer patients: a prospective transvaginal ultrasound study (TVUS). Proc Am Soc Clin Oncol 22:69"},{"key":"9941_CR10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/annonc\/mdi021","volume":"16","author":"L Morales","year":"2005","unstructured":"Morales L, Timmerman D, Neven P et al (2005) Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients. Ann Oncol 16:70\u201374","journal-title":"Ann Oncol"},{"key":"9941_CR11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ygyno.2006.04.004","volume":"103","author":"G Garuti","year":"2006","unstructured":"Garuti G, Cellani F, Centinaio G, Montanari G, Nalli G, Luerti M (2006) Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors. Gynecol Oncol 103:599\u2013603","journal-title":"Gynecol Oncol"},{"key":"9941_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10549-006-9285-x","volume":"101","author":"O Markovitch","year":"2007","unstructured":"Markovitch O, Tepper, Fishman A, Aviram R, Cohen I (2007) Aromatase inhibitors reverse tamoxifen induced endometrial ultrasonographic changes in postmenopausal breast cancer patients. Breast Cancer Res Treat 101:185\u2013190","journal-title":"Breast Cancer Res Treat"},{"key":"9941_CR13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1158\/1078-0432.CCR-05-0225","volume":"12","author":"B Gerber","year":"2006","unstructured":"Gerber B, Krause A, Reimer T et al (2006) Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen- induced endometrial pathology. Clin Cancer Res 12:1245\u20131250","journal-title":"Clin Cancer Res"},{"key":"9941_CR14","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1200\/JCO.1999.17.7.2050","volume":"17","author":"CDB Love","year":"1999","unstructured":"Love CDB, Muir BB, Scrimgeour JB, Leonard RCF, Dillon P, Dixon JM (1999) Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol 17:2050\u20132054","journal-title":"J Clin Oncol"},{"key":"9941_CR15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1200\/JCO.1996.14.2.434","volume":"14","author":"A Decensi","year":"1996","unstructured":"Decensi A, Fontana V, Bruno S, Gustavino C, Gotteschi B, Casta A (1996) Effect of tamoxifen on endometrial proliferation. J Clin Oncol 14:434\u2013440","journal-title":"J Clin Oncol"},{"key":"9941_CR16","doi-asserted-by":"crossref","unstructured":"Berliere M, Galant C, Charles A et al (2002) Endometrial evaluation is a very important tool in the management of breast cancer patients. Eur J Cancer (Suppl) 6: S67\u2013S68","DOI":"10.1016\/S0959-8049(02)00292-7"},{"key":"9941_CR17","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1471-0528.2000.tb11104.x","volume":"107","author":"I Cohen","year":"2000","unstructured":"Cohen I, Beyth Y, Azaria R et al (2000) Ultrasonographic measurement of endometrial changes following discontinuation of tamoxifen treatment in postmenopausal breast cancer patients. Brit J Obstet Gynecol 107:1083\u20131087","journal-title":"Brit J Obstet Gynecol"},{"key":"9941_CR18","first-page":"321","volume":"25","author":"MV Menada","year":"2004","unstructured":"Menada MV, Papadia A, Lorenzi P et al (2004) Modification of ultrasonographically measured endometrial thickness after discontinuation of adjuvant therapy with tamoxifen in postmenopausal breast cancer patients. Eur J Gynaec Oncol 25:321\u2013323","journal-title":"Eur J Gynaec Oncol"},{"key":"9941_CR19","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1200\/JCO.2005.01.7657","volume":"23","author":"F Boccardo","year":"2005","unstructured":"Boccardo F, Rubagotti A, Puntoni M et al (2005) Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian tamoxifen anastrozole trial. J Clin Oncol 23:5238\u20135247","journal-title":"J Clin Oncol"},{"key":"9941_CR20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ygyno.2004.07.019","volume":"95","author":"T Hachisuga","year":"2004","unstructured":"Hachisuga T, Saito T, Kigawa J et al (2004) Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for breast cancers. Gynecol Oncol 95:139\u2013144","journal-title":"Gynecol Oncol"},{"key":"9941_CR21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ygyno.2005.10.026","volume":"101","author":"SE Ferguson","year":"2005","unstructured":"Ferguson SE, Solow RA, Amsterdam A et al (2005) Comparison of uterine malignancies that develop during and following tamoxifen therapy. Gynecol Oncol 101:322\u2013326","journal-title":"Gynecol Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-9941-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-008-9941-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-9941-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:32:13Z","timestamp":1559233933000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-008-9941-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,23]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["9941"],"URL":"https:\/\/doi.org\/10.1007\/s10549-008-9941-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,23]]}}}